Business
Final results for the year ended 31 December 2022
Final results for the year ended 31 December 2022.
About this update from Oxford Nanopore Technologies Plc
[{"type":"text","content":"\n \n \n This announcement contains inside information.\n \n \n 21 March 2023\n \n \n \n Oxford Nanopore Technologies plc\n \n \n \n \n Final results for the year ended 31 December 2022\n \n \n \n \n \n Strong underlying\n \n [1]\n \n LSRT revenue growth of 30% in 2022, driven by innovation and customer acquisition; \n expect underlying annual LSRT revenue growth of more than 30% in both 2023 and in the medium term, reflecting the continued growth and diversification of the broader user base\n \n \n \n \n \n \n \n Oxford Nanopore Technologies plc (LSE: ONT) (\"Oxford Nanopore\" or the \"Group\"),\n \n the company delivering a new generation of molecular sensing technology based on nanopores\n , today announces its final results for the year ended 31 December 2022.\n \n \n \n Gordon Sanghera, Chief Executive Officer, commented:\n \n \n \n \"2022 was another year of significant progress for Oxford Nanopore. Demand for our differentiated technology continues to grow around the world and across many areas of scientific research, including human, cancer, animal, plant, pathogen and environmental genomics. This has underpinned a 30.5% growth in active customer accounts and underlying LSRT revenue growth of 30% despite a challenging macroeconomic environment. We have remained relentlessly focused on innovation, with the well-received new technologies launched in 2022 further strengthening Oxford Nanopore's unique position as a highly accessible, accurate, information rich platform at any scale.\n \n \n \"This platform makes us well-placed to capture the significant opportunities we see ahead, both in scientific research and beyond. The partnerships we have signed in the last year start to demonstrate the attractiveness of our technology in the clinical and applied markets and provide a strong foundation for further progress.\n \n \n \"We\n \n \n enter 2023 with good momentum\n . Our balance sheet remains strong and we will continue to invest in ground-breaking innovations and\n operational expansion \n to support continuous growth and deliver long-term value for shareholders\n .\"\n \n \n \n \n \n \n \n Summary financial performance\n \n \n \n \n \n \n \n \n £ million\n \n \n \n Unless otherwise stated\n \n \n \n \n \n 2022\n \n \n \n \n \n \n 2021\n \n \n \n \n \n \n Change\n \n \n \...